Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Nektar Therapeutics (NKTR) Ownership - Who Owns Nektar Therapeutics?
1,203 Followers
Nektar Therapeutics (NKTR) Ownership Overview
12.30% Insiders
19.91% Mutual Funds
9.53% Other Institutional Investors
58.26% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail and individual investors. Approximately 29.44% of the company’s stock is owned by Institutional Investors, 12.30% is owned by Insiders and 58.26% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 20, 2024 | Howard Robin President & Ceo,director | xxxxxxxxxxxxx | $29138 |
| May 20, 2024 | Jonathan Zalevsky Chief R&d Officer | xxxxxxxxxxxxx | $12871 |
| May 13, 2024 | Deep Track Capital, Lp >10% Owner | xxxxxxxxxxxxx | $99120 |
| Feb 22, 2024 | Howard Robin President & Ceo,director | xxxxxxxxxxxxx | $13622 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $6506848 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,700,000 | Institution | 10.16% | 26,554,000 | |
| 12,380,982 | Institution | 6.73% | 17,580,994 | |
| 9,106,419 | Institution | 4.95% | 12,931,115 | |
| 6,966,647 | Institution | 3.79% | 9,892,639 | |
| 6,305,736 | Institution | 3.43% | 8,954,145 | |
| 6,282,444 | Institution | 3.41% | 8,921,070 | |
| 2,280,412 | Institution | 1.24% | 3,238,185 | |
| 1,853,483 | Institution | 1.01% | 2,631,946 | |
| 1,709,346 | Institution | 0.93% | 2,427,271 | |
| 1,641,025 | Institution | 0.89% | 2,330,256 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,380,982 | Institution | 6.73% | 17,580,994 | |
| 6,305,736 | Institution | 3.43% | 8,954,145 | |
| 2,280,412 | Institution | 1.24% | 3,238,185 | |
| 1,853,483 | Institution | 1.01% | 2,631,946 | |
| 1,709,346 | Institution | 0.93% | 2,427,271 | |
| 1,641,025 | Institution | 0.89% | 2,330,256 | |
| 1,181,405 | Institution | 0.64% | 1,677,595 | |
| 1,113,883 | Institution | 0.61% | 1,581,714 | |
| 795,362 | Institution | 0.43% | 1,129,414 | |
| 703,443 | Institution | 0.38% | 998,889 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,724,732 | Institution | 3.11% | 7,270,410 | |
| 4,250,173 | Institution | 2.31% | 5,780,235 | |
| 2,808,231 | Institution | 1.53% | 3,566,453 | |
| 1,648,416 | Institution | 0.90% | 2,241,846 | |
| 847,351 | Institution | 0.46% | 1,152,397 | |
| 531,382 | Institution | 0.29% | 754,562 | |
| 573,456 | Institution | 0.31% | 728,289 | |
| 383,855 | Institution | 0.21% | 545,074 | |
| 136,872 | Institution | 0.07% | 186,146 | |
| 122,266 | Institution | 0.07% | 166,282 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 9.53% of the company's stock is held by institutional investors, 12.30% is held by insiders, and 58.26% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.53% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.26% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
Peter Kolchinsky owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.